PT Lautan Luas Tbk (LTLS.JK)
Jakarta, JK, ID
PT Lautan Luas Tbk, together with its subsidiaries, manufactures and distributes basic and specialty chemicals in Indonesia and internationally. It operates in three segments: Distribution; Manufacturing; and Services. The company offers integrated logistics services, including contract and outsourcing logistics, warehouse package and bulk services, bulk product management, stevedoring, cold chain, cold and liquid storage, kitting and co-packaging, freight forwarding, export import expedition, customs brokerage, 3P logistics, and e-fulfilment, as well as cargo, domestics distribution, and transportation services. It also provides water solution services, such as consultation, send water sample, water sample test, results and recommendation, survey, proposal, transaction, payment and schedule, installation, and checking services through WATERCARE; and water treatment products with multimedia filter, ultra-filtration, UV, Ion-exchange, reverse osmosis and other technologies through PUREVE; and water treatment services, as well as IT consultant and management services. In addition, the company offers sulfuric acid; laboratory services and solutions; integrated end-to-end logistics and supply chain business, and information technology solutions. Further, it provides non-dairy creamer; glucose; and refilled drinking water, as well as produces and distributes chemical products. It serves pharmaceutical and health care, food and beverages, industrial drinking and wastewater, personal and household care, automotive, animal feed, building construction, agriculture, mining, textile and apparel, as well as pulp, paper, and packaging industries. The company was formerly known as Perusahaan Andil Maskapai Dagang dan Industri Lim Teck Lee and changed its name to PT Lautan Luas Tbk in 1965. The company was founded in 1951 and is headquartered in Jakarta Barat, Indonesia. PT Lautan Luas Tbk is a subsidiary of PT Caturkarsa Megatunggal.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.91% | +4.76% | -1.28% | -4.94% | -10.47% | -10.98% | -15.38% | -33.91% | +38.74% | +142.14% | +305.26% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +7.2%+13.9% ★ Q1'26: +6.3% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +16.5%-31.9% Q1'26: -4.4% (vs Q1'25)
-
FCF margin Chemicals - Specialty: +27.4%+2.2% Q1'26: +8.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +9.5%+4.8% Q1'26: +4.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +6.2%+7.1% ★ Q1'26: +7.1% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.0%-0.4% ★ Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Chemicals - Specialty: 0.21×2.17× Q1'26: 1.90× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-14 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-13 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-10 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Elly Mariana Tansil | Finance Director & Director | — | female |
| Eurike Hadijaya | Investor Relations & Corporate Communications Manager | — | — |
| Hendrik Gunawan | Director of Business Development & Director | — | male |
| Indrawan Masrin | President Director | — | male |
| Joshua Chandraputra Asali | MD, Business Development Director, Secretary & Director | — | male |
| Keyne Fredella Kristanto | Corporate Legal & Corporate Secretary | — | — |
| Shiska Valentina | Head of Internal Audit Division | — | female |
| Soewandhi Soekamto | Commercial Director & Director | — | male |
| Subakti Setiawan | Director of Supply Chain & Director | — | male |
| Tje Wie Jap | Officer of Process Engineering | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LTLS.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
